Please use this identifier to cite or link to this item:
https://doi.org/10.21767/AMJ.2017.3136
DC Field | Value | |
---|---|---|
dc.title | Myoclonus from antibiotic therapy (Ceftazidime-induced Neurotoxicity): A case study and review | |
dc.contributor.author | Ong, C.Y | |
dc.contributor.author | Qin, Y | |
dc.date.accessioned | 2020-10-23T04:55:51Z | |
dc.date.available | 2020-10-23T04:55:51Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Ong, C.Y, Qin, Y (2017). Myoclonus from antibiotic therapy (Ceftazidime-induced Neurotoxicity): A case study and review. Australasian Medical Journal 10 (9) : 811-815. ScholarBank@NUS Repository. https://doi.org/10.21767/AMJ.2017.3136 | |
dc.identifier.issn | 18361935 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/179544 | |
dc.description.abstract | A 78-year-old Chinese man with a history of end stage renal disease (ESRD) presented with fever of one day duration. He was treated for catheter related sepsis with intravenous piperacillin and tazobactam, which was later switched to vancomycin and ceftazidime secondary to persistent fever with negative cultures. One the fifth day of treatment with vancomycin and ceftazidime, he developed new onset upper limb myoclonus which progressed to bilateral upper limb ataxia. A provisional diagnosis of myoclonus and ataxia secondary to neurotoxicity related to ceftazidime was made and the ceftazidime was ceased. His symptoms resolved over three days and he returned to his baseline neurological status by Day 5 following cessation. @ 2017, Australasian Medical Journal Pty Ltd. All rights reserved. | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | ceftazidime | |
dc.subject | piperacillin plus tazobactam | |
dc.subject | vancomycin | |
dc.subject | aged | |
dc.subject | antibiotic therapy | |
dc.subject | arteriovenous fistula | |
dc.subject | artery occlusion | |
dc.subject | ataxia | |
dc.subject | case report | |
dc.subject | Chinese | |
dc.subject | clinical article | |
dc.subject | drug withdrawal | |
dc.subject | end stage renal disease | |
dc.subject | fever | |
dc.subject | fistuloplasty | |
dc.subject | hemodialysis | |
dc.subject | human | |
dc.subject | male | |
dc.subject | medical device complication | |
dc.subject | myoclonus | |
dc.subject | Review | |
dc.subject | sepsis | |
dc.subject | vascular surgery | |
dc.type | Review | |
dc.contributor.department | DUKE-NUS MEDICAL SCHOOL | |
dc.description.doi | 10.21767/AMJ.2017.3136 | |
dc.description.sourcetitle | Australasian Medical Journal | |
dc.description.volume | 10 | |
dc.description.issue | 9 | |
dc.description.page | 811-815 | |
dc.published.state | Published | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_21767_AMJ_2017_3136.pdf | 528.51 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License